BRCA2 and cancer: In a pan-cancer analysis of BRCA1 and BRCA2 genomic alterations using hybrid captured-based comprehensive genomic profiling, the fraction of BRCA1/2 altered biallelic cases was 68.7%, which is highly associated with elevated genome-wide loss of heterozygosity (gLOH) (59).